Serum Institute of India (SII)
-
Johns Hopkins Bloomberg School Of Public Health felicitates Dr Cyrus S Poonawalla
Dr Poonawalla bagged the award for his lifelong contribution to this honour, reserved for luminaries demonstrating exceptional leadership in safeguarding…
Read More » -
Novavax, SII receive emergency use authorisation for COVID-19 caccine in the Philippines
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name COVOVAX Novavax and Serum…
Read More » -
Novavax, SII submits modules for COVID-19 vaccine to regulatory agencies in India, Indonesia, Philippines
A submission to the World Health Organization (WHO) for emergency use listing (EUL) based on the DCGI submission is expected…
Read More » -
CII, SII to expand vaccination across small towns, rural areas
CII is mapping vaccination need requirement state-wise and setting up vaccination camps The Confederation of Indian Industry (CII) has partnered…
Read More » -
India seeks funds from Quad alliance to match China’s vaccine push: Source
India has urged the US, Japan and Australia to invest in its vaccine production capacity India has urged the US,…
Read More » -
Delhi HC directs covid vaccine providers to disclose manufacturing capacities
The Centre has been asked to explain in an affidavit the rationale behind keeping strict control over the class of…
Read More »
